Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OptimizeRx (OPRX) Revenue (2016 - 2026)

OptimizeRx's Revenue history spans 16 years, with the latest figure at $32.2 million for Q4 2025.

  • On a quarterly basis, Revenue changed 0.24% to $32.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $109.4 million, a 18.78% increase, with the full-year FY2025 number at $109.4 million, up 18.78% from a year prior.
  • Revenue hit $32.2 million in Q4 2025 for OptimizeRx, up from $26.1 million in the prior quarter.
  • Over the last five years, Revenue for OPRX hit a ceiling of $32.3 million in Q4 2024 and a floor of $11.2 million in Q1 2021.
  • Historically, Revenue has averaged $19.8 million across 5 years, with a median of $19.2 million in 2022.
  • Biggest five-year swings in Revenue: decreased 6.45% in 2022 and later skyrocketed 55.19% in 2025.
  • Tracing OPRX's Revenue over 5 years: stood at $20.3 million in 2021, then decreased by 3.24% to $19.7 million in 2022, then soared by 44.34% to $28.4 million in 2023, then increased by 13.91% to $32.3 million in 2024, then dropped by 0.24% to $32.2 million in 2025.
  • Business Quant data shows Revenue for OPRX at $32.2 million in Q4 2025, $26.1 million in Q3 2025, and $29.2 million in Q2 2025.